MAPT and early-onset autosomal dominant Alzheimer disease: Moreover, Gebre and colleagues introduced an advanced tau summary measure that quantifies tau deposition heterogeneity into a single number, called the Tau Heterogeneity Evaluation in Alzheimer’s Disease (THETA).